Type 2 Diabetes Treatment - Part 6 - SGLT2 Inhibitors
Published September 26, 2018
|
20 min
    Download
    Add to queue
    Copy URL
    Show notes
    Sodium-Glucose Transporter 2 Inhibitors decrease glucose re-absorbtion. The diuretic effect, weight loss, DKA, cardiac outcomes, blood pressure, genital infections and a whole bunch of other information is discussed. SGLT2s include Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance), Ertagliflozin (Steglatro), with more to be released in the future.
      15
      15
        0:00:00 / 0:00:00